V
Vincent Cottin
Researcher at Claude Bernard University Lyon 1
Publications - 675
Citations - 29630
Vincent Cottin is an academic researcher from Claude Bernard University Lyon 1. The author has contributed to research in topics: Idiopathic pulmonary fibrosis & Medicine. The author has an hindex of 68, co-authored 574 publications receiving 21594 citations. Previous affiliations of Vincent Cottin include University of Lyon & Institut national de la recherche agronomique.
Papers
More filters
Journal ArticleDOI
Essais cliniques au cours de la fibrose pulmonaire idiopathique: le choix des critères de jugement
Vincent Cottin,Yurdagül Uzunhan +1 more
Journal ArticleDOI
Fibrose pulmonaire au cours des vascularites associées aux ANCA : un facteur pronostique
T. Maillet,T. Goletto,H. Dupuy,Stéphane Jouneau,Vincent Cottin,Hervé Devilliers,Estibaliz Lazaro,P. Bonniaud,Xavier Puéchal,L. Guillevin,Benjamin Terrier,Maxime Samson,Groupe français d’étude des vascularites +12 more
TL;DR: L’atteinte pulmonaire etait definie par une PID de type usuelle (UIP) ou non specifique (PINS) (criteres ATS/ERS de 2001) selon les resultats du scanner thoracique selon la nomenclature de Chapel Hill revisee en 2012.
Journal ArticleDOI
[Rare pulmonary diseases: from the adoption of orphan diseases to structured healthcare networks].
Proceedings ArticleDOI
Decline in Forced Vital Capacity (FVC) in Patients with Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD) in Consecutive 6-Month Periods of the SENSCIS Trial
Bruno Crestani,Stéphane Jouneau,Vanessa Smith,V. Steen,Anna-Maria Hoffmann-Vold,Francesco Del Galdo,Margarida Alves,C. Stock,Vincent Cottin,on behalf of the SENSCIS trial investigators +9 more
Journal ArticleDOI
Treatable traits: a comprehensive precision medicine in interstitial lung disease.
Yet H. Khor,Vincent Cottin,Anne E Holland,Yoshikazu Inoue,Vanessa M. McDonald,Justin M. Oldham,Elisabetta A. Renzoni,Anne-Marie Russell,Mary E. Strek,Christopher J. Ryerson +9 more
TL;DR: In this paper , a framework of aetiological, pulmonary, extra-pulmonary, and behavioural and lifestyle treatable traits relevant to clinical care and outcomes for patients with ILD is proposed.